This Article Full Text Full Text (PDF) All Versions of this Article: 108/21/2716    most recent 01.CIR.0000096489.40209.DDv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pellis, T. Articles by Checchia, P. Search for Related Content PubMed PubMed Citation Articles by Pellis, T. Articles by Checchia, P. Related Collections CPR and emergency cardiac care

(Circulation. 2003;108:2716.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Evidence Favoring the Use of an ₂-Selective Vasopressor Agent for Cardiopulmonary Resuscitation

Tommaso Pellis, MD; Max Harry Weil, MD, PhD; Wanchun Tang, MD; Shijie Sun, MD; Jing Xie, MD; Lei Song, MD; Paul Checchia, MD

From the Institute of Critical Care Medicine, Palm Springs, Calif (T.P., M.H.W., W.T., S.S., J.X., L.S.); the Keck School of Medicine of the University of Southern California, Los Angeles (M.H.W., W.T., S.S.); and Loma Linda University Medical Center, Loma Linda, Calif (P.C.).

Correspondence to Max Harry Weil, MD, PhD, The Institute of Critical Care Medicine, 1695 N Sunrise Way, Bldg 3, Palm Springs, CA 92262. E-mail weilm{at}911research.org

Received March 18, 2003; revision received July 23, 2003; accepted July 26, 2003.

Background— Both ₁- and ß-adrenergic agonists increase the severity of global myocardial ischemic injury. We hypothesized that combined ß- and ₁-adrenergic blockade would improve initial resuscitation and postresuscitation myocardial and neurological functions. We further hypothesized that the resulting ₂-actions of relatively brief duration would favor improved functions compared with the more prolonged effect of nonadrenergic vasopressin.

Methods and Results— Three groups of 5 male domestic pigs weighing 37±3 kg were investigated. Ventricular fibrillation was untreated for 7 minutes before the start of precordial compression, mechanical ventilation, and attempted defibrillation. Animals were randomized to receive central venous injections of equipressor doses of (1) epinephrine, (2) epinephrine in which both ₁- and ß-adrenergic effects were blocked by previous administration of prazosin and propranolol, and (3) vasopressin during CPR. All but 1 animal were successfully resuscitated. After injection of epinephrine, significantly better cardiac output and fractional area change, together with lesser increases in troponin I, were observed after ₁- and ß-adrenergic blockade. Postresuscitation neurological function was also improved after ₁- and ß-block in comparison with unblocked epinephrine and after vasopressin.

Conclusions— Equipressor doses of epinephrine, epinephrine after ₁- and ß-adrenergic blockade, and vasopressin were equally effective in restoring spontaneous circulation after prolonged ventricular fibrillation. However, combined ₁- and ß-adrenergic blockade, which represented a predominantly selective ₂-vasopressor effect, resulted in improved postresuscitation cardiac and neurological recovery.

Key Words: cardiopulmonary resuscitation • epinephrine • receptors, adrenergic, alpha • receptors, adrenergic, beta • vasopressin

This article has been cited by other articles:

				L. Huang, M. H. Weil, S. Sun, W. Tang, and X. Fang Carvedilol Mitigates Adverse Effects of Epinephrine During Cardiopulmonary Resuscitation Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2005; 10(2): 113 - 120. [Abstract] [PDF]

				A. M. Zafari, S. K. Zarter, V. Heggen, P. Wilson, R. A. Taylor, K. Reddy, A. G. Backscheider, and S. C. Dudley Jr A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy J. Am. Coll. Cardiol., August 18, 2004; 44(4): 846 - 852. [Abstract] [Full Text] [PDF]

				S. Sun, M. H. Weil, W. Tang, T. Kamohara, and K. Klouche {delta}-Opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H969 - H974. [Abstract] [Full Text] [PDF]